SCHEMBL4669534

SCHEMBL4669534

Cc1[nH]c2c(F)ccc(C)c2c1CCNC(=O)/C=C/c1cccc(C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC4 P56524 3/20 0.42
MEF2D Q14814 2/20 0.42
MMP1 P03956 3/20 0.41
MMP2 P08253 3/20 0.41
MMP9 P14780 3/20 0.41
P4HB P07237 1/20 0.39
POLB P06746 1/20 0.39
RECQL P46063 1/20 0.39
HDAC1 Q13547 3/20 0.39
HDAC2 Q92769 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TTR P02766 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4754641 0.93 MEN1 (0.42) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4667869 0.93 MEN1 (0.42) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4018968 0.90 MEN1 (0.44) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4017825 0.90 MMP1 (0.50) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4017742 0.89 MMP1 (0.53) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4015839 0.87 MEN1 (0.44) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4017504 0.86 HPGD (0.53) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4668491 0.86 KDM4E (0.48) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL4752607 0.86 KDM4E (0.48) HPGDALDH1A1MEN1KMT2AHDAC4
SCHEMBL13982459 0.86 HPGD (0.45) HPGDALDH1A1MEN1KMT2AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed